SCFD2: A Potential Drug Target for Various Diseases (G152579)

Target Name: SCFD2

NCBI ID: G152579

SCFD2

SCFD2: A Potential Drug Target for Various Diseases

SCFD2 (stimulated controlled fusion domain 2) is a protein that is expressed in the human placenta, specifically in the villus epithelial cells. It is a key regulator of the cell cycle, and is involved in the development and maintenance of normal cell growth and differentiation.

Recent studies have identified SCFD2 as a potential drug target for various diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. This is due to its unique structure and its involvement in multiple cellular processes that are important for human health.

One of the key reasons for the potential of SCFD2 as a drug target is its unique structure. SCFD2 is a transmembrane protein that is composed of four domains: a catalytic domain, a transmembrane domain, a nucleotide-binding domain, and a C-terminal domain. The transmembrane domain is responsible for the protein's ability to interact with the cell membrane, and the catalytic domain is responsible for its catalytic activity.

The catalytic domain of SCFD2 is unique in that it contains a specific active site that is involved in the regulation of cell cycle progression. This site is known as the \"fusion domain\" and is located at the interface between the catalytic domain and the transmembrane domain.

Studies have shown that the fusion domain of SCFD2 plays a crucial role in the regulation of cell cycle progression. By interacting with specific DNA sequences, the fusion domain allows SCFD2 to regulate the movement of chromatin during the cell cycle. This regulation is important for the proper functioning of the cell, as the cell cycle is responsible for the growth and division of cells.

Another potential drug target for SCFD2 is its involvement in multiple cellular processes that are important for human health. For example, SCFD2 has been shown to be involved in the regulation of cell adhesion, a process that is important for the development and maintenance of tissues and organs.

In addition, SCFD2 has also been shown to be involved in the regulation of cell proliferation, a process that is essential for the growth and development of all tissues and organs. The proper regulation of cell proliferation is important for the prevention of cancer and other diseases.

The potential of SCFD2 as a drug target is also due to its unique expression pattern. SCFD2 is highly expressed in the human placenta, specifically in the villus epithelial cells. This makes it an attractive target for drugs that can modulate its expression and activity in these cells.

In conclusion, SCFD2 is a unique protein that is involved in multiple cellular processes that are important for human health. Its unique structure and its involvement in the regulation of cell cycle progression and cell proliferation make it an attractive target for drugs that can modulate its expression and activity. Further studies are needed to fully understand the potential of SCFD2 as a drug target and to develop effective treatments for various diseases.

Protein Name: Sec1 Family Domain Containing 2

Functions: May be involved in protein transport

The "SCFD2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCFD2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets